Share
Journal Information
Special article
Special article
Ibero-american rheumatology
SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment
Javier Narváez, Petra Díaz del Campo Fontecha, Noé Brito García, Gema Bonilla, Myriam Aburto, Iván Castellví, Esteban Cano-Jiménez, Natalia Mena-Vázquez, ... José Antonio Rodríquez Portal
Reumatol Clin. 2022;18:501-12
Full text access
Open Article
Original articles
Predictive factors for the development of lupus nephritis after diagnosis of systemic lupus erythematosus
Miguel Estévez del Toro, Iter Varela Ceballos, Araceli Chico Capote, Elena Kokuina, Yeniset Sánchez Bruzón, Nelsa Casas Figueredo
Reumatol Clin. 2022;18:513-7
Full text access
Open Article
Determinants of therapeutic success of corticoids injections in trigger finger syndrome
Carlos Antonio Guillén Astete, Rocío Rodriguez López, Nuria García Montes
Reumatol Clin. 2022;18:518-22
Full text access
Open Article
Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study
Roxana González Mazarío, Jorge Juan Fragío Gil, José Ivorra Cortés, Elena Grau García, Antonio José Cañada Martínez, Luis González Puig, Rosa María Negueroles Albuixech, José Andrés Román Ivorra
Reumatol Clin. 2022;18:523-30
Full text access
Open Article
Relationship between polyautoimmunity and sarcopenic obesity in rheumatoid arthritis patients
Natalia Mena-Vázquez, Sara Manrique-Arija, María Carmen Ordoñez-Cañizares, Rocio Redondo-Rodriguez, José Rioja Villodres, Laura Cano-Garcia, Francisco Javier Godoy-Navarrete, Francisco Gabriel Jiménez Nuñez, ... Antonio Fernández-Nebro
Reumatol Clin. 2022;18:531-7
Full text access
Open Article
Association between fibromyalgia syndrome clinical severity and body composition. A principal component analysis
José Álvarez-Nemegyei, Elda Leonor Pacheco-Pantoja, Lililana Judith Olán-Centeno, Angélica Angulo-Ramírez, Fernanda Elizabeth Rodríguez-Magaña, José Fernando Aranda-Muiña
Reumatol Clin. 2022;18:538-45
Full text access
Open Article
Impact of lung ultrasound during the SARS-CoV-2 pandemic: Distinction between viral and bacterial pneumonia
Yale Tung-Chen, Alejandro Giraldo Hernández, Alberto Mora Vargas, Laura Dorado Doblado, Patricia Elsa González Merino, Ángela Valencia Alijo, Jesús Herraiz Jiménez, Ángela Gutiérrez Rojas, ... Esther Montero Hernández
Reumatol Clin. 2022;18:546-50
Full text access
Open Article
Original articles
Ibero-american rheumatology
Prevalence of rheumatic diseases in Baix Empordà
Marta Larrosa Padró, José Maria Inoriza, Ramón Valls Garcia, Eulàlia Armengol Pérez, Joan M. Nolla, Jordi Coderch de Lassaletta, Xavier Perez Berruezo
Reumatol Clin. 2022;18:551-6
Open access
Open Article
Case report
Crohn’s disease in a patient with systemic onset juvenile idiopathic arthritis. Association or associated side effect of treatment?
Laura Martín Pedraz, Rocío Galindo Zavala, Javier Blasco Alonso, Víctor Manuel Navas López, Esmeralda Núñez Cuadros
Reumatol Clin. 2022;18:557-9
Full text access
Open Article
Letters to the editor
When the usual doses are not enough
María José Macías Reyes, Andrea Pluma Sanjurjo, Sara Marsal Barril, María Dolors Grados Canovas
Reumatol Clin. 2022;18:560-1
Full text access
Open Article
Outcomes of Pregnancy in Women With Idiopathic Inflammatory Myopathies in Africa
Mickael Essouma, Jean Jacques Noubiap
Reumatol Clin. 2022;18:561-3
Full text access
Open Article
The Value of a Negative Antinuclear Antibody (ANA) Test: An Often Forgotten Result
Adrian Y.S. Lee
Reumatol Clin. 2022;18:563-4
Full text access
Open Article
Letters to the Editor
Ibero-american rheumatology
How do Spanish Rheumatologists handle referral? Survey of knowledge and approach before and after a training workshop
Alejandro Balsa, Isidoro González-Álvaro, Raimon Sanmartí, Hector Corominas
Reumatol Clin. 2022;18:564-6
Full text access
Open Article
Special content about COVID-19
- Spontaneous pneumomediastinum: An extra muscular manifestation of anti-MDA5 dermatomyositis. Report of 2 cases
- The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam
- Analysis of factors involved in the development of humoral response to vaccination against SARS-CoV-2 in patients with rheumatic pathology under biological treatment
- The “autoimmune/inflammatory syndrome induced by adjuvants” (ASIA) after COVID-19 infection: A case report
Publish in
Reumatología Clínica